Tuberculosis trials and consortium

Active Definitive Contract Awarded Last action

Contract number
75D30121C10168
Awardee
Awarding agency
Obligated
$6,640,604

Award facts

Opportunity
Contract value 67% obligated
  • $6,640,603.74 Current, with exercised options
  • $9,856,205.74 Potential, with all options
Completion date 59% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 22 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Cape Town, 7700, South Africa
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00010 · EO 14398/exercise option period 6 $1,017,474
Other Administrative Action P00009 · EO 14398 $0
Exercise an Option P00008 $994,681
Exercise an Option P00007 $914,196
Exercise an Option P00006 $1,040,894
Exercise an Option P00005 $860,438
Other Administrative Action P00003 $0
Supplemental Agreement for work within scope P00004 $0
Exercise an Option P00002 $850,470
Supplemental Agreement for work within scope P00001 $0
Original award $962,451
Show all 11

About this award

The Centers for Disease Control and Prevention awarded a definitive cost-no-fee contract to The Medical University Of South Carolina for tuberculosis trials and consortium clinical research support on December 17, 2020, with a ceiling value of $9,856,205.74. No set-aside was used, and the funding agency record lists CDC Pittsburgh as an alternate name. The prime is a state-controlled institution and a child entity of the State of South Carolina. The current action exercises option period 6 under EO 14398, with ultimate completion on December 31, 2030. Place of performance is Cape Town, 7700, South Africa.

Three subcontractors are named: University of Cape Town (pharmacokinetics work for TBTC Study 39), University Of Cape Town Lung Institute (Pty) LTD (maintaining TBTC study capacity at its site), and Vanderbilt University Medical Center (site principal investigator for the Vanderbilt TBTC site). The originating pre-solicitation, posted February 5, 2020 with responses due February 14, 2020, sought ten years of clinical research support for tuberculosis treatment, diagnosis, and prevention. Requirements include participation in clinical studies, study start-up procedures, and membership in the Tuberculosis Trials Consortium as a member site. Evaluation considers a vendor's ability to perform multiple protocols concurrently. The government estimated up to four new studies between the base year and ninth option year. Contract value and task order amounts were to be determined.

Service Contract Inventory data for FY2025 show 6.8 FTEs across 14,235 contractor hours, $476 thousand invoiced, and a derived government-paid rate of $33.42/hr. Three subcontractors were reported, with 85% of FY2025 contractor hours subcontracted out. Derived rates across reported years are declining: $87.34/hr in FY2021 (civilian-only inventory), $24.98/hr in FY2024 ($1 million invoiced, 19.8 FTEs, 41,195 hours), and $33.42/hr in FY2025. The source describes these rates as approximate because they blend prime and subcontractor figures, and it flags the FY2021 coverage change as complicating cross-year comparison.

Subawards

Subcontractor Amount Awarded
University Of Cape Town TUBERCULOSIS TRIALS AND CONSORTIUM A1 5/12/2025 the scope of pharmacokinetics-related work to be undertaken by the University of Cape Town (South Africa) in… $38,359
Vanderbilt University Medical Center TUBERCULOSIS TRIALS AND CONSORTIUM A2 3/22/2024 A1 2/21/2023 Timothy R. Sterling, MD, will serve as the Site Principal Investigator will devote 5% effort in… $48,017
University Of Cape Town Lung Institute (Pty) LTD TUBERCULOSIS TRIALS AND CONSORTIUM A4 2/26/2025 A3 4/29/2024 A2 3/31/2023 A1 3/31/2022 Maintain capacity for conduct of TBTC clinical studies in the following… $3,036,194

Quick answers

Who was awarded contract 75D30121C10168?

75D30121C10168 was awarded to The Medical University Of South Carolina by CDC Pittsburgh (Centers for Disease Control and Prevention) on December 17, 2020.

How much is contract 75D30121C10168 worth?

The government has obligated $6,640,604 on 75D30121C10168. Its potential value, with all options, is $9,856,206.

Was contract 75D30121C10168 competed?

The extent of competition for 75D30121C10168 was full and open competition. The government received 22 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award